Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib and Bevacizumab in Platinum-sensitive Recurrent Ovarian Cancer
NCT04734665Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in ovarian cancer, sponsored by Yonsei University. Status: unknown.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT04734665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04734665.